Top Markets
#1 DogBull DogBull +106.14%
#2 Siacoin Siacoin +53.78%
#3 ADO Protocol ADO Protocol +50.84%
#4 The Bitcoin Bull The Bitcoin Bull +43.39%
#5 龙虾 (Lobster) 龙虾 (Lobster) +36.69%
#6 MarsCoin MarsCoin +35.12%
#7 Glidr Glidr +25.30%
#8 UnifAI Network UnifAI Network +19.90%
#9 Ontology Gas Ontology Gas +19.05%
#10 Falcon Finance Falcon Finance +16.87%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Guhan Pharmaceutical Group Co., Ltd. Guhan Pharmaceutical Group Co., Ltd.

Guhan Pharmaceutical Group Co., Ltd.

000590
Rank in Stocks #15811
Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries,... Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries, operates as a prominent Chinese pharmaceutical enterprise. The company focuses on the production and distribution of traditional Chinese medicine (TCM), conventional chemical pharmaceuticals, and health supplements within the domestic market. Its business activities are organized into specific segments, including the manufacturing and sale of traditional Chinese medicine, the manufacturing and sale of Western medicine, and a range of other operations. The company boasts a comprehensive product catalog featuring both prescription and over-the-counter (OTC) drugs. This selection includes tonics and health-boosting preparations, medications for cardiovascular and cerebrovascular conditions, nutritional products for children, cold and flu remedies, and detoxifying agents. Beyond its core manufacturing, Guhan Pharmaceutical is involved in a diverse array of additional services and ventures. These encompass health and nutrition advisory services, the cultivation of Chinese medicinal herbs, extensive medical research and experimental development, planning for cultural and artistic exchanges, general medical consultations, online sales, technology promotion, consulting agent services, outpatient care, and comprehensive pharmaceutical wholesale and retail operations. Founded in 1956, the company is headquartered in Hengyang, China. It was previously known as Tus-Pharmaceutical Group Co., Ltd., officially adopting its current name, Guhan Pharmaceutical Group Co., Ltd., in November 2025.
Share Price
$1.37
Market Cap
$328.98M
Change (1 day)
0.64%
Change (1 year)
-20.55%
Country
CN
Trade Guhan Pharmaceutical Group Co., Ltd. (000590)

Category

Healthcare
Revenue for Guhan Pharmaceutical Group Co., Ltd. (000590)
Revenue in Sep 2026 TTM: 0
According to Guhan Pharmaceutical Group Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Guhan Pharmaceutical Group Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US